Shares of Global Medical REIT Inc (NYSE:GMRE) have received an average recommendation of “Buy” from the seven brokerages that are currently covering the firm, Marketbeat Ratings reports. Two research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 12 month price target among brokerages that have issued ratings on the stock in the last year is $10.61.
A number of analysts have recently weighed in on the stock. TheStreet raised shares of Global Medical REIT from a “c+” rating to a “b” rating in a research note on Thursday, May 9th. Zacks Investment Research raised shares of Global Medical REIT from a “hold” rating to a “buy” rating and set a $11.00 price target for the company in a research note on Wednesday, February 13th. Boenning Scattergood reaffirmed a “buy” rating and issued a $11.00 price target on shares of Global Medical REIT in a research note on Friday, May 10th. Stifel Nicolaus assumed coverage on shares of Global Medical REIT in a research note on Monday, April 15th. They issued a “buy” rating and a $11.00 price target for the company. Finally, B. Riley set a $11.00 price target on shares of Global Medical REIT and gave the stock a “buy” rating in a research note on Friday, March 8th.
In other news, Director Roscoe M. Moore, Jr. sold 5,945 shares of the company’s stock in a transaction that occurred on Monday, March 18th. The shares were sold at an average price of $9.75, for a total value of $57,963.75. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 11.70% of the company’s stock.
Shares of NYSE:GMRE traded down $0.04 during trading on Wednesday, reaching $10.78. The company had a trading volume of 210,600 shares, compared to its average volume of 312,147. The firm has a market cap of $362.58 million, a P/E ratio of 13.82, a P/E/G ratio of 1.57 and a beta of 0.46. Global Medical REIT has a twelve month low of $8.10 and a twelve month high of $11.11. The company has a current ratio of 0.08, a quick ratio of 0.08 and a debt-to-equity ratio of 0.76.
Global Medical REIT (NYSE:GMRE) last issued its quarterly earnings results on Wednesday, May 8th. The company reported $0.02 earnings per share for the quarter, missing analysts’ consensus estimates of $0.20 by ($0.18). The company had revenue of $15.20 million during the quarter, compared to analyst estimates of $15.32 million. Global Medical REIT had a return on equity of 5.52% and a net margin of 21.38%. Equities research analysts forecast that Global Medical REIT will post 0.77 EPS for the current year.
Global Medical REIT Company Profile
Global Medical REIT, Inc engages in the acquisition of purpose-built healthcare facilities and leasing of those properties to strong healthcare systems and physician groups. The company was founded on March 18, 2011 and is headquartered in Bethesda, MD.
Further Reading: What are the benefits of a balanced fund?
Receive News & Ratings for Global Medical REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Medical REIT and related companies with MarketBeat.com's FREE daily email newsletter.